Sitagliptin/Empagliflozin FDC Improves Glycaemic Control with Good Safety: Study
Researchers have found in a new study that fixed-dose combination of sitagliptin and empagliflozin significantly improved glycaemic control at 24 weeks, with sustained benefits up to 52 weeks. The therapy…